Video file
Please connect to access this resource and get a more personalized Campus experience
Executive summary

ConformalFLASH combines the biological tissue sparing effects of FLASH with physics sparing effects of Proton Bragg Peak.

IBA is investing heavily in developing this novel technique utilizing the Bragg peak called ConformalFLASH®. IBA’s strategy to take FLASH today from research to a clinical version of ConformalFLASH® will take into consideration the radiobiology, clinical safety, and future streamlined workflow for FLASH.

Flash Therapy is currently under research and development phase and will be available for sale when regulatory clearance is received.

Key content topics
Guest speakers
Swati
Girdhani
Director of Research Collaborations​
IBA
Nicolas
Denef
Emerging Therapies Director
IBA